Evofem Biosciences, Inc. SEC filings EVFM

Evofem Biosciences, Inc. has 802 filings in SEC EDGAR's recent list, going back to Sep 12, 2014. Its latest annual report, Form 10-K, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (material agreement). The company's fiscal year ends on December 31.

Evofem Biosciences, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Oct 15, 2026 Oct 9, 2026
8-K Current report
Material agreement
Sep 23, 2026 Sep 17, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jul 20, 2026 Jul 20, 2026
8-K Current report
Material agreement, New debt
Jul 14, 2026 Jul 8, 2026
8-K Current report
Results of operations
May 18, 2026 May 18, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Apr 30, 2026 Apr 24, 2026
8-K Current report
Material agreement
Apr 16, 2026 Apr 10, 2026
8-K Current report
Agreement ended
Mar 19, 2026 Mar 13, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Mar 11, 2026 Mar 11, 2026
10-K Annual report Mar 11, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Nov 26, 2025 Nov 26, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
DEF 14A Proxy statement Oct 29, 2025 Oct 29, 2025
PRE 14A Preliminary proxy statement Oct 20, 2025 Oct 20, 2025
8-K Current report
Agreement ended, Shareholder vote results, Regulation FD disclosure
Oct 20, 2025 Oct 20, 2025
8-K Current report
Material agreement
Oct 17, 2025 Oct 13, 2025
DEFA14A Additional proxy material Sep 19, 2025 —
DEFA14A Additional proxy material Sep 9, 2025 —
DEFM14A Filing Sep 8, 2025 —
PREM14A Filing Aug 26, 2025 Aug 26, 2025
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
Aug 26, 2025 Aug 22, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
DEF 14C Information statement Aug 6, 2025 Aug 5, 2025
PREM14A Filing Jul 24, 2025 Jul 24, 2025
PRE 14C Filing Jul 9, 2025 Jul 9, 2025
8-K Current report
Material agreement, Unregistered share sale
Jul 2, 2025 Jun 26, 2025
D Filing Jul 2, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
May 22, 2025 May 19, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
8-K Current report
Material agreement
May 8, 2025 May 3, 2025
D Filing Apr 15, 2025 —
8-K Current report
Material agreement
Apr 14, 2025 Apr 8, 2025
8-K Current report
Material agreement
Apr 3, 2025 Mar 28, 2025
10-K/A Amended annual report Mar 28, 2025 Dec 31, 2024
8-K Current report
Material agreement
Mar 26, 2025 Mar 20, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 24, 2025 Mar 24, 2025
10-K Annual report Mar 24, 2025 Dec 31, 2024
8-K Current report
Listing notice
Jan 10, 2025 Jan 6, 2025
8-K Current report
Other events
Dec 23, 2024 Dec 23, 2024
8-K Current report
Material agreement
Nov 25, 2024 Nov 19, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
8-K Current report
Material agreement
Nov 6, 2024 Oct 31, 2024
8-K Current report
Material agreement, Agreement ended
Oct 31, 2024 Oct 27, 2024
8-K Current report
Material agreement, Unregistered share sale
Oct 28, 2024 Oct 28, 2024
8-K Current report
Material agreement, Unregistered share sale
Oct 3, 2024 Sep 27, 2024
8-K Current report
Material agreement, Unregistered share sale
Sep 25, 2024 Sep 20, 2024
PRE 14A Preliminary proxy statement Sep 23, 2024 Sep 23, 2024
8-K Current report
Material agreement
Sep 6, 2024 Sep 6, 2024
8-K Current report
Listing notice
Aug 30, 2024 Aug 28, 2024
D Filing Aug 21, 2024 —
D Filing Aug 21, 2024 —
8-K Current report
Material agreement
Aug 20, 2024 Aug 16, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 23, 2024 Jul 17, 2024
8-K Current report
Material agreement, Other events
Jul 18, 2024 Jul 14, 2024
8-K Current report
Material agreement
Jul 18, 2024 Jul 12, 2024
8-K Current report
Regulation FD disclosure
Jul 18, 2024 Jul 17, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jun 26, 2024 Jun 20, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Material agreement, Agreement ended
May 2, 2024 Apr 26, 2024
8-K Current report
Regulation FD disclosure
Mar 28, 2024 Mar 27, 2024
10-K Annual report Mar 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 27, 2024 Mar 27, 2024
8-K Current report
Material agreement, Other events
Mar 6, 2024 Feb 29, 2024
8-K Current report
Results of operations
Feb 1, 2024 Feb 1, 2024
8-K Current report
Material agreement
Jan 31, 2024 Jan 30, 2024
8-K/A Amended current report Jan 25, 2024 Dec 21, 2023
8-K Current report
Material agreement
Jan 11, 2024 Jan 8, 2024
8-K Current report
Material agreement
Dec 27, 2023 Dec 21, 2023
8-K Current report
Material agreement, Agreement ended, Bylaw or fiscal year change, Regulation FD disclosure
Dec 12, 2023 Dec 11, 2023
8-K Current report
Material agreement
Dec 7, 2023 Dec 1, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
Results of operations
Oct 24, 2023 Oct 24, 2023
D Filing Oct 11, 2023 —
8-K Current report
Material agreement
Oct 3, 2023 Sep 27, 2023
8-K Current report
Other events
Sep 27, 2023 Sep 27, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Sep 15, 2023 Sep 14, 2023
8-K Current report
Material agreement, New debt
Sep 11, 2023 Sep 8, 2023
DEF 14A Proxy statement Aug 29, 2023 Aug 29, 2023
8-K Current report
Regulation FD disclosure
Aug 28, 2023 Aug 25, 2023
PRER14A Filing Aug 18, 2023 —
8-K/A Amended current report
Material agreement, Shareholder vote results
Aug 18, 2023 Aug 10, 2023
EFFECT Filing Aug 14, 2023 —
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
424B3 Prospectus Aug 14, 2023 —
S-1/A Amended registration statement Aug 11, 2023 —
PRE 14A Preliminary proxy statement Aug 11, 2023 Aug 10, 2023
CORRESP Letter to the SEC Aug 10, 2023 —
8-K Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results
Aug 10, 2023 Aug 4, 2023
S-1/A Amended registration statement Aug 3, 2023 —
CORRESP Letter to the SEC Aug 3, 2023 —
UPLOAD Letter from the SEC Jul 19, 2023 —
8-K Current report
Change to shareholder rights, Auditor change, Bylaw or fiscal year change
Jul 17, 2023 Jul 11, 2023
8-K Current report
Material agreement
Jul 10, 2023 Jul 3, 2023
S-1 Registration statement Jul 10, 2023 —
8-K Current report
Shareholder vote results
Jun 20, 2023 Jun 20, 2023
10-Q Quarterly report Jun 16, 2023 Mar 31, 2023
8-K Current report
Results of operations
Jun 16, 2023 Jun 16, 2023
8-K Current report
Results of operations
Jun 1, 2023 Jun 1, 2023
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
May 17, 2023 May 17, 2023
NT 10-Q Filing May 12, 2023 Mar 31, 2023
8-K Current report
Other events
May 5, 2023 Apr 27, 2023
DEF 14A Proxy statement May 1, 2023 Jun 20, 2023
8-K Current report
Results of operations
Apr 28, 2023 Apr 28, 2023
10-K Annual report Apr 27, 2023 Dec 31, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 14, 2023 Apr 13, 2023
8-K/A Amended current report
Material agreement
Apr 12, 2023 Apr 5, 2023
8-K Current report
Material agreement, Officer or director change
Apr 10, 2023 Apr 5, 2023
NT 10-K Filing Mar 31, 2023 Dec 31, 2022
8-K Current report
Material agreement
Mar 24, 2023 Mar 20, 2023
8-K Current report
Exit or restructuring costs, Officer or director change, Other events
Mar 21, 2023 Mar 17, 2023
8-K Current report
Shareholder vote results
Mar 17, 2023 Mar 15, 2023
8-K Current report
Material agreement, Other events
Mar 14, 2023 Mar 13, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 7, 2023
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Mar 9, 2023 Mar 3, 2023
D Filing Mar 6, 2023 —
8-K Current report
Other events
Feb 24, 2023 Feb 23, 2023
8-K Current report
Material agreement
Feb 23, 2023 Feb 17, 2023
DEFA14A Additional proxy material Feb 17, 2023 —
8-K Current report
Officer or director change
Feb 16, 2023 Feb 10, 2023
DEF 14A Proxy statement Feb 15, 2023 Mar 15, 2023
D Filing Feb 3, 2023 —
PRE 14A Preliminary proxy statement Jan 27, 2023 Jun 22, 2022
8-K Current report
Other events
Jan 12, 2023 Jan 12, 2023
8-K Current report
Other events
Jan 10, 2023 Jan 10, 2023
8-K Current report
Other events
Jan 9, 2023 Jan 9, 2023
10-Q Quarterly report Jan 6, 2023 Sep 30, 2022
8-K Current report
Other events
Dec 30, 2022 Dec 29, 2022
8-K Current report
Material agreement, Officer or director change, Bylaw or fiscal year change
Dec 21, 2022 Dec 16, 2022
NT 10-Q Filing Nov 14, 2022 Nov 14, 2022
8-K Current report
Exit or restructuring costs
Nov 2, 2022 Nov 1, 2022
25-NSE Delisting notice Oct 27, 2022 —
8-K Current report
Officer or director change
Oct 14, 2022 Oct 10, 2022
8-K Current report
Other events
Oct 12, 2022 Oct 11, 2022
8-K Current report
Listing notice
Oct 6, 2022 Oct 3, 2022
8-K Current report
Regulation FD disclosure
Oct 5, 2022 Oct 5, 2022
EFFECT Filing Sep 30, 2022 —
424B3 Prospectus Sep 30, 2022 —
CORRESP Letter to the SEC Sep 28, 2022 —
UPLOAD Letter from the SEC Sep 28, 2022 —
S-1 Registration statement Sep 23, 2022 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Sep 16, 2022 Sep 12, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Listing notice
Aug 10, 2022 Aug 9, 2022
8-K Current report
Regulation FD disclosure
Aug 4, 2022 Aug 4, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change
Aug 3, 2022 Aug 2, 2022
8-K Current report
Other events
Jun 14, 2022 Jun 8, 2022
8-K Current report
Material agreement
May 31, 2022 May 27, 2022
8-K Current report
Regulation FD disclosure
May 26, 2022 May 26, 2022
8-K Current report
Material agreement, Other events
May 23, 2022 May 19, 2022
424B5 Prospectus supplement May 23, 2022 —
424B5 Prospectus supplement May 20, 2022 —
8-K Current report
Agreement ended
May 20, 2022 May 18, 2022
8-K Current report
Regulation FD disclosure
May 12, 2022 May 12, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results, Other events
May 5, 2022 May 4, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 7, 2022 —
DEFA14A Additional proxy material Apr 7, 2022 —
8-K Current report
Listing notice, Other events
Apr 7, 2022 Apr 6, 2022
DEFA14A Additional proxy material Apr 7, 2022 —
8-K Current report
Material agreement, New debt
Apr 7, 2022 Apr 4, 2022
DEF 14A Proxy statement Mar 30, 2022 Mar 30, 2022
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
Mar 24, 2022 Mar 24, 2022
8-K Current report
Material agreement, New debt
Mar 21, 2022 Mar 21, 2022
PRE 14A Preliminary proxy statement Mar 18, 2022 Mar 18, 2022
S-8 Employee stock plan registration Mar 10, 2022 —
10-K Annual report Mar 10, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 3, 2022 Mar 3, 2022
424B5 Prospectus supplement Mar 1, 2022 —
8-K Current report
Material agreement, New debt
Mar 1, 2022 Mar 1, 2022
8-K Current report
Listing notice
Feb 28, 2022 Feb 22, 2022
424B5 Prospectus supplement Feb 16, 2022 —
8-K/A Amended current report
Material agreement
Feb 16, 2022 Feb 15, 2022
8-K Current report
Material agreement
Feb 16, 2022 Feb 15, 2022
8-K Current report
Regulation FD disclosure
Feb 15, 2022 Feb 15, 2022
8-K Current report
Results of operations
Jan 19, 2022 Jan 19, 2022
424B5 Prospectus supplement Jan 13, 2022 —
8-K Current report
Material agreement, New debt
Jan 13, 2022 Jan 13, 2022
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Dec 15, 2021 Dec 15, 2021
DEFA14A Additional proxy material Dec 9, 2021 —
8-K Current report
Regulation FD disclosure
Dec 9, 2021 Dec 9, 2021
DEFA14A Additional proxy material Dec 8, 2021 —
8-K Current report
Other events
Dec 8, 2021 Dec 8, 2021
DEFA14A Additional proxy material Nov 22, 2021 —
8-K Current report
Material agreement, New debt, Other events
Nov 22, 2021 Nov 20, 2021
8-K Current report
Officer or director change
Nov 19, 2021 Nov 17, 2021
8-K Current report
Regulation FD disclosure
Nov 15, 2021 Nov 15, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EVFM (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1618835
Former names
Neothetics, Inc. (until Jan 5, 2018)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.